Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neulasta in Traumatic Optic Neuropathy
NCT06168188Phase 1Recruiting
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of pegfilgrastim in traumatic optic neuropathy (TON), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: Best Corrected Visual Acuity at 3 months. Started Jul 2020; status: recruiting.
02
Drugs
pegfilgrastim
03
Conditions
traumatic optic neuropathy (TON)
Beyond the preview
Go deeper on NCT06168188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06168188.